Drug Shortage Report for SODIUM BICARBONATE INJECTION, USP
Report ID | 143253 |
Drug Identification Number | 02486636 |
Brand name | SODIUM BICARBONATE INJECTION, USP |
Common or Proper name | Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq (mmol), 50 mL Vial |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM BICARBONATE |
Strength(s) | 84MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 50 mL |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-08-01 |
Actual start date | |
Estimated end date | 2021-08-16 |
Actual end date | 2021-08-16 |
Shortage status | Resolved |
Updated date | 2021-08-17 |
Company comments | Fresenius Kabi Canada Ltd. regrets to advise that due to a production delay, our Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq (mmol), 50 mL Vial will be going on backorder, effective August 1, 2021 until August 20, 2021. Omega is an alternate supplier of Sodium Bicarbonate Injection, USP, 8.4% and has been informed of our impending supply interruption. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-07-29 | English | Compare |
v2 | 2021-07-29 | French | Compare |
v3 | 2021-08-02 | English | Compare |
v4 | 2021-08-16 | English | Compare |
v5 | 2021-08-16 | French | Compare |
v6 | 2021-08-17 | English | Compare |
Showing 1 to 6 of 6